Na Qu
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Cancer-related molecular mechanisms research
Papers in ⓘ
-
- RNA modifications and cancer 4
- Oncology 10
- Cancer Cells and Metastasis 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Lesheng Teng (4 shared papers)Congying Wang (1 shared paper)Ming Zhang (1 shared paper)Yating Sun (3 shared papers)Ben‐Zhan Zhu (3 shared papers)Chengxia Kan (6 shared papers)Xiaodong Sun (6 shared papers)Fengping Shan (10 shared papers)
- Journals
- International Immunopharmacology (10 papers)Biochemical Pharmacology (3 papers)Proceedings of the National Academy of Sciences (2 papers)International Journal of Nanomedicine (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Na Qu
54 papers receiving 740 citations
Peers
Comparison fields: 5 of 115
- Biomaterials 141
- Cancer Research 111
- Pharmaceutical Science 34
- Molecular Biology 365
- Virology 23
Countries citing papers authored by Na Qu
This map shows the geographic impact of Na Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Qu more than expected).
Fields of papers citing papers by Na Qu
This network shows the impact of papers produced by Na Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Qu. The network helps show where Na Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Na Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 72 | |
| 2 | 2022 | 62 | |
| 3 | 2019 | 58 | |
| 4 | 2016 | 56 | |
| 5 | 2024 | 53 | |
| 6 | 2016 | 49 | |
| 7 | 2010 | 41 | |
| 8 | 2016 | 32 | |
| 9 | 2019 | 27 | |
| 10 | 2022 | 24 | |
| 11 | 2022 | 21 | |
| 12 | 2018 | 21 | |
| 13 | 2020 | 20 | |
| 14 | 2016 | 18 | |
| 15 | 2019 | 12 | |
| 16 | 2024 | 11 | |
| 17 | 2021 | 11 | |
| 18 | 2019 | 10 | |
| 19 | 2011 | 10 | |
| 20 | 2021 | 9 |
About Na Qu
Na Qu is a scholar working on Molecular Biology, Oncology, Psychiatry and Mental health, Epidemiology and Immunology, having authored 56 papers that have together received 754 indexed citations. Recurring topics across this work include Cancer, Stress, Anesthesia, and Immune Response (8 papers), Autophagy in Disease and Therapy (5 papers), Neuropeptides and Animal Physiology (5 papers), Cancer Cells and Metastasis (4 papers), Nanoparticle-Based Drug Delivery (4 papers), RNA modifications and cancer (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Biomaterials (141 citations), Cancer Research (111 citations), Pharmaceutical Science (34 citations), Molecular Biology (365 citations) and Virology (23 citations). Na Qu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Lesheng Teng, Congying Wang, Ming Zhang, Yating Sun, Ben‐Zhan Zhu, Chengxia Kan, Xiaodong Sun, Fengping Shan, Liang‐Hong Guo and Ningning Hou. Their work appears in journals such as International Immunopharmacology, Biochemical Pharmacology, Proceedings of the National Academy of Sciences, International Journal of Nanomedicine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.